Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: Erratum
- PMID: 31490219
- PMCID: PMC7060045
- DOI: 10.1097/01.aids.0000579184.27339.a8
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: Erratum
Erratum for
-
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).AIDS. 2017 Jan 28;31(3):321-332. doi: 10.1097/QAD.0000000000001276. AIDS. 2017. PMID: 27677160
-
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.AIDS. 2018 Nov 13;32(17):2533-2545. doi: 10.1097/QAD.0000000000002026. AIDS. 2018. PMID: 30289805 Free PMC article. Clinical Trial.
References
-
- Guardo AC, Joe PT, Miralles L, Bargalló ME, Mothe B, Krasniqi A, et al. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix). AIDS 2017; 31:321–332. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
